BioCentury
ARTICLE | Clinical News

AVI preclinical data

June 13, 2005 7:00 AM UTC

In a mouse model of prostate cancer, intraperitoneal administration of Neugene, a neutrally charged antisense-based androgen receptor antagonist, downregulated androgen receptor levels. Significant pr...